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Abstract Site-directed mutagenesis was used to alter putative 
active site residues in the large subunit of calpain, and the activity 
of the mutants was measured following coexpression i  E. coli of 
both calpain subunits and purification of the resultant dimers. 
Mutants Cysl05Ser, His262Ala and Asn286Ala had no activity. 
Together with sequence comparisons among cysteine proteinases, 
the results suggest that these residues constitute the catalytic 
triad in calpain. Mutants Asn286Asp and Trp288Tyr had low 
activity, consistent with interaction of these residues with His262. 
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1. Introduction 
The calpains (EC 3.4.22.17) are cytoplasmic Ca2+-dependent 
cysteine proteinases, found in most cell types of vertebrates and 
also in some other species (Drosophila nd Schistosoma mansoni 
[1-3]. Two forms, p- and m-calpain (calpain I and calpain II), 
have been well characterized from mammalian tissue. They 
have similar substrate specificities, but differ in their Ca 2+- 
requirements when assayed in vitro, p-calpain requiring ~ 50 pM 
Ca 2+ for half-maximal activity and m-calpain 400 ¢tM Ca 2+. 
Both enzymes consist of a catalytic subunit (80 kDa) and a 
regulatory subunit (30 kDa). The large subunits of p- and 
m-calpain are genetically distinct in a given species, while the 
small subunits are identical. The 3D structure of calpain has 
not yet been solved, but on the basis of amino acid sequence 
it appears that the large subunits consist of four domains [4]. 
Domain II contains the active site residues, while domain IV 
of the large subunit (as well as the C-terminal domain of the 
small subunit) contains everal EF hand sequences which may 
bind Ca 2+. 
All cysteine proteinases so far characterized involve a pair 
of cysteine-histidine residues at the active site, referred to as the 
catalytic S-IImH + ion pair [5,6]. Very little biochemical infor- 
mation is available about the active site of calpain, but the 
active site cysteine residue was identified as C105 by means of 
labelling with [14C]iodoacetic a id [7], and this has been con- 
firmed recently by mutagenesis [8]. Sequence comparisons 
among cysteine proteinases have suggested that H262 in calpain 
is likely to be the second component of the catalytic ion pair, 
and that N286 could be involved in stabilising this ion pair 
[4,5,9]. There are several other residues near the active site 
which are highly conserved throughout the different families of 
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cysteine proteinases, but the reasons for their strict conserva- 
tion are in many cases not yet clear. 
The calpains form a distinct family within the general class 
of cysteine proteinases. Although domain II of calpain has 
sometimes been described as papain-like, the percent amino 
acid sequence identity with papain and with other cysteine 
proteinases i low, and is insufficient to provide structural in- 
formation. A further difference is that the pK a values of the 
presumed catalytic ion pair in calpain are different from those 
of other cysteine proteinases [10], suggesting differences in the 
active site regions. For these reasons, predictions about calpain 
activity based on papain or similar proteinases must be made 
with care. 
There are other major distinctions which make the calpains 
worthy of further study. Most obviously, the regulation of 
calpain by Ca 2+ represents a level of control not seen in the 
other cysteine proteinases. This regulation isgenerally assumed 
to involve a couformational change in calpain induced by Ca 2+- 
binding to the C-terminal domains of both subunits, although 
the mechanism whereby this change affects the active site resi- 
dues in domain II remains to be established. 
In addition to these considerations, the possible involvement 
of calpain in several disease states [11] makes it a potential drug 
target, and a precise description of the active site region would 
help in drug design. For calpain, the recent development of a 
satisfactory bacterial expression system [8,12] has made possi- 
ble a study of active site residues by means of site-directed 
mutagenesis, and we report here some results of this approach 
applied to recombinant rat m-calpain. 
2. Materials and methods 
2.1. Materials 
Native m-calpain isolated from mammalian tissues consists of an 
80+30-kDa dimer, the smaller subunit of which is very rapidly N- 
terminally truncated by autolysis when the enzyme is activated [13]. The 
rat m-calpain defined in this paper as wild-type was obtained by coex- 
pression in E. coli of an intact large subunit (80 kDa) with a truncated 
form (21 kDa) of the small subunit which corresponds closely to the 
natural autolysis product [8]. The numbering of residues in the calpain 
large subunit is that of human and rat m-calpain [14]. 
2.2. Mutagenesis 
Mutants of the large subunit were made in the wild-type clone in 
pETo24d(+) by site-directed mutagenesis. Antisense primers with 
the sequences: 5'-ccagaagc~tccccaagggc-3'(C105S); 5'-gacggag- 
tacgaggatcctttcaccaact-3'(H262A); 5'-tgtccccagggggccctgatacgtatc- 
3'(N286A); 5'-gtccccaggggtcgcgaatacgtatcaa-Y(N286D); and 5'-ctccac- 
ttgtccatatgggttcctgatac-3'(W288Y) were used, and in each case gave rise 
to a diagnostic restriction site (underlined). The sequences around the 
mutation sites were confirmed by DNA sequencing. 
2.3. Expression and purification 
The calpain large subunit mutants and a 21-kDa fragment of the rat 
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small subunit were coproduced from compatible plasmids in E. coli 
BL21(DE3), and the resulting calpains were purified by chromatogra- 
phy on DEAE-Sepharose and Spectra/Gel AcA 44 as previously de- 
scribed [8,12]. A final step of purification was carried out on an FPLC 
Q-Sepharose column. All buffers used contained 5 mM EDTA, 10 mM 
fl-mercaptoethanol and 0.2 mg/ml PMSF to minimise oxidation or 
breakdown of calpain during purification. 
Gel electrophoresis, and determination f calpain activities and pro- 
tein concentladons, were carried out as previously described [8,12]. 
2.4. Light scattering 
Light scattering was measured using a Perkin Elmer LS50 fluorome- 
ter equipped with a magnetic stirrer under the cuvette holder. Emission 
and excitation wavelengths were both set at 340 nm, with slit widths of 
10 nm, and the light source was attenuated using the machine filter. 
Calpain samples (75 /2g/ml, 0.75 /tM) were briskly stirred at room 
temperature in 5 mM Tris-HC1, 1 mM EDTA, pH 8.0; after observing 
base-line values, the rate of increase of light scattering was measured 
for several minutes following addition of CaC12 to a net final concentra- 
tion of 2 mM. The aggregation was reversible on addition of excess 
EDTA. 
3. Results 
All five calpain mutants described here (C105S, H262A, 
N286A, N286D and W288Y) were produced as hetero-dimers 
at protein levels similar to those obtained with the active wild- 
type enzyme, and at least 70% of the expressed protein was 
recovered in the soluble fraction after sonication of the cells. 
During purification of the mutants, the major calpain-contain- 
ing peaks eluted in the positions expected for wild-type calpain. 
The cell lysates for two of the mutants (H262A and N286A) 
contained a slightly higher proportion of aggregated or par- 
tially unfolded calpain which was separated out during purifi- 
cation. The purity of the mutants after the FPLC Q-Sepharose 
column is shown in Fig. 1. 
On measurement of Ca>-dependent proteinase activity, with 
casein as substrate, the W288Y mutant was found to be the 
most active of the mutants, with a specific activity of 128 U/mg 
(Table 1). This value is ~5% of that of the wild-type enzyme, 
which is 2300 U/mg [8]. The shape of the Ca>-titration curve 
for the W288Y mutant, but not the [Ca 2+] required for 50% of 
maximum activity, was significantly altered from that of the 
wild-type enzyme (Fig. 2). The N286D mutant showed a very 
slight activity of 22 U/mg, and the C105S, H262A and N286A 
mutant dimers showed no activity, even when 60 ¢tg of calpain 
were included in the assay. The active site concentrations of
these mutants could not be determined by inhibitor titration 
due to their low or non-existent activities. 
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Fig. 1. 12.5% acrylamide SDS Tris-glycine gel, stained with Coomassie Brilliant Blue. The calpains hown are: wild-type, C105S, H262A, N286A, 
N286D and W288Y (lanes 2-7, left to right). Molecular weight standards (lanes 1 and 8) correspond to 97, 66, 45, 31, 21 and 14 kDa. 
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Fig. 2. Ca>-dependence of calpain activity. Enzyme samples were di- 
alysed against 5 mM EDTA, and their activity in the standard casein 
assay was measured at net Ca > concentrations from 0.25-5 mM. Con- 
trol values observed in the presence of 5 mM EDTA were set at 0%. 
The points represent the mean and standard eviations of triplicate 
observations. Wild-type calpain, • W288Y, ©. 
Aggregation of the mutant enzymes in the presence of 2 mM 
Ca > was measured by means of right-angled light scattering, 
and was used as an indication that the protein was folded 
sufficiently well to undergo a Ca2+-induced conformational 
change. The mutants and wild-type calpains showed similar 
aggregation behaviour (Table 1), with the exception of W288Y, 
which aggregated more slowly. 
4. Discussion 
All of the mutants behaved indistinguishably from the wild- 
type enzyme during expression and purification, as dimers of 
80- and 21-kDa subunits. Densitometry of Coomassie-stained 
gels of the purified mutants howed subunit ratios identical to 
that of the wild-type enzyme, consistent with a subunit stoi- 
chiometry of 1:1 (Fig. 1). Apart from W288Y which is discussed 
later, the responses of the mutants to Ca > were very similar to 
that of the wild-type nzyme. The available vidence of soluble 
expression, dimer formation, chromatographic behaviour and 
Ca2+-dependent aggregation therefore suggests that the mutant 
proteins were correctly folded. 
The active site of papain contains an S-/ImH + ion pair (C25/ 
H159), which is thought o be stabilised by a hydrogen bond 
between the side chains of H159 and N175 [6]. Since these 
residues are conserved in over 95% of all cysteine proteinases 
[5,9], it has been commonly assumed that the corresponding 
residues in calpain were C105, H262, and N286. The mutation 
C105S in calpain produced inactive nzyme, as observed previ- 
ously in the C105A mutant [8]. The lack of activity of the 
calpain H262A mutant confirms the previous uggestion based 
on kinetic and pH data that a histidine was involved in the 
active site [10], and identifies the particular histidine residue. 
The lack of activity of the N286A mutant, in turn, suggests that 
a hydrogen bond between H262 and N286 is important for 
stabilisation of the ion pair in calpain. These results provide 
strong experimental evidence that cysteine-105, histidine-262 
and asparagine-286 constitute the catalytic triad in calpain. 
Conversion of the papain active site cysteine residue to serine 
(as with the calpain C105S mutant) caused loss of activity, 
which was attributed to a difference in length between a C-O 
and C-S bond [15,16]. This may not however be the only factor 
involved. The active site thiol group in the cysteine proteinases 
is ionized, and therefore strongly nucleophilic, because of its 
interaction with a histidine residue. When the cysteine is re- 
placed with a serine residue, the histidine and asparagine resi- 
dues in the mutant triad are apparently unable to promote 
sufficiently the nucleophilicity of the serine oxygen atom. Al- 
though some cysteine proteinases have been successfully con- 
verted to serine proteinases, these were viral 'trypsin-like' cyste- 
ine proteinases which may have an aspartic or glutamic acid 
residue, rather than an asparagine, in their catalytic triads 
[17,18]. Conversely, it is of interest to note that double mutation 
of trypsin to generate a cysteine/histidine/asparagine triad re- 
sulted in loss of activity [19]. 
The amide protons of N175 in papain are in a hydrophobic 
environment close to W177 [20]. Mutations of N175 in pro- 
papain have shown that it is required for normal processing and 
activity of the enzyme [21], and more recent work suggests that 
mutations in this position affect both structure and function (R. 
Menard, pers. commun.). In calpain, we thought hat an aspar- 
tate at position 286 might increase the reactivity of C105 by 
interacting more strongly with H262, but in practice the N286D 
nmtant had very low activity. It is not yet clear whether this is 
due to a failure of D286 to adopt a conformation capable of 
interacting with H262; or to a change in conformation ofW288 
caused by the hydrophilic nature of D286. Although this tryp- 
tophan is totally conserved in all calpain and papain-like se- 
quences, its role is not clear, and several possibilities exist. It 
may form part of the Sl' binding site, (A. Storer, pers. com- 
mun.), it may shield the asparagine-histidine hydrogen bond 
from water [6], or it may interact directly with the ion pair 
histidine, as in the ribonuclease barnase [6,22]. The calpain 
W288Y mutant retained some activity (~5% of the wild-type) 
indicating that although not absolutely essential, this trypto- 
phan residue must make a significant contribution either to 
catalysis or to substrate binding. The slightly altered response 
of the W288Y mutant to Ca 2+ may imply some change in 
conformation. 
Table 1 
Calcium-dependent proteolysis and aggregation of calpain mutants 
Calpain" Specific Aggregation ° 
activity b 
Wild-type 2,300 0.13 
C105S 0 0.11 
H262A 0 0.15 
N286A 0 0.10 
N286D 22 0.13 
W288Y 128 0.06 
"The wild-type or mutant large subunits were coexpressed with the 
21-kDa small subunit and purified. 
b Specific activity in the standard casein assay, U/mg protein. 
~Arbitrary units, indicating the rate of increase of light scattering 
signal/s. 
400 
Other amino acid residues in the immediate vicinity of the 
catalytic triad in calpain must influence the reactivity of the 
central nucleophilic group, as well as contributing to substrate 
specificity. It is hoped that the recent development of an effi- 
cient expression system for calpain [8,12] will permit the com- 
bined use of mutagenesis and crystallization to investigate the 
fine details of its structure and mechanism. 
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